Session I Abstracts

Click on abstract for more information

Session	Title	Author
S1	COMPARISON OF TWO REAL TIME PCR METHODS AND A CONVENTIONAL PCR TEST FOR THE QUANITIFICATION OF CYTOMEGALOVIRUS (CMV) IN PLASMA	Michael S Forman and Alexandra Valsamakis Division of Medical Microbiology, Department of Pathology, The Johns Hopkins Medical Institution, Baltimore, MD
S2	PERFORMANCE EVALUATION OF THE ARTUS CYTOMEGALOVIRUS (CMV) PCR ASSAY FOR ANALYTICAL AND CLINICAL SENSITIVITY	M. L. Ackerman, D. Johnson and S. E. Dale Hamilton Regional Laboratory Medicine Program (HRLMP), St Josephs Healthcare, Hamilton, ON, CANADA
S3	DETERMINATION OF CMV VIRAL LOAD BY ARTUS (QIAGEN) CMV REAL-TIME PCR ANALYTE-SPECIFIC REAGENT USING LIGHTCYCLER	Darren Baker, Mary Otto, and Rangaraj Selvarangan, Ph.D, Department of Pathology and Laboratory Medicine, Childrens Mercy Hospitals and Clinics, Kansas City, MO
S4	DETECTION OF CYTOMEGALOVIRUS IN CLINICAL SAMPLES USING THREE DIFFERENT REAL-TIME PCR CHEMISTRIES	Erica Vincent1, Zhengming Gu1, Markus Morgenstern1, Candace Gibson1, Jianmin Pan2, and Randall T. Hayden1 Departments of 1Pathology, and 2Biostatistics St. Jude Children?s Research Hospital, Memphis, TN 38105
S5	PERFORMANCE CHARACTERISTICS OF A MULTICODE-RTx® PCR ASSAY FOR THE QUANTITATIVE DETECTION OF CYTOMEGALOVIRUS DNA IN PLASMA AND URINE	Kalpana Ramachandran and Charles P. Cartwright ViroMed (LabCorp) Laboratories, Minnetonka, MN
S6	COMPARISON OF AN IN-HOUSE DEVELOPED AND TWO COMMERCIAL ASSAYS (LIGHT TM AND CMV BRITETM )FOR QUANTIFICATION OF HUMAN CYTOMEGALOVIRUS PP65-ANTIGENEMIA	Elena Percivalle, Antonella Chiesa, and Giuseppe Gerna*Servizio di Virologia, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
S7	ASSESSMENT OF PERFORMANCE OF QUALITY CONTROL SAMPLES USED IN REAL TIME QUANTITATIVE PCR FOR MONITORING VIRAL LOAD OF CMV, EBV, BKV IN ORGAN TRANSPLANT RECIPIENTS	Xiaoli Pang and Jutta Preiksaitis Provincial Laboratory for Public Health (Microbiology), Edmonton, Alberta, Canada
S8	POLYMORPHISMS OF GENES IN HCMV UL/B' REGION OF CLINICAL STRAINS	Ruan Qiang, He Rong, Sun Zhengrong, Ji Yaohua, Qi Ying, Ma YanPing, Mao ZhiQin, Huang YuJing Virus Laboratory, Shengjing Hospital, China Medical University, Shenyang, 110004 P.R.China
S9	THREE CMV pp65 ANTIGENEMIA ASSAYS VERSUS QUANTITATIVE REAL TIME PCR AN UNJUST COMPARISON	Suzanne Hansen1, Angie Rounsavall1, Christopher Hemphil1, Sherry Childress1, Stephanie Stovall1,2, and Stefan Juretschko1,21ACH, Arkansas Children's Hospital, Little Rock, AR and 2UAMS, University of Arkansas for Medical Sciences, Little Rock, AR
S10	HIGH CMV IgM ANTIBODY LEVELS CORRELATE WITH LOW CMV IgG AVIDITY AND MAY BE A USEFUL INDICATOR OF PRIMARY CMV INFECTION	Sheila C. Dollard, Stephanie A.S. Staras, Minal A. Amin, and Michael J. Cannon Centers for Disease Control and Prevention, Atlanta, GA
S11	INITIAL EVALUATION OF BECKMAN SPRI-TE SYSTEM FOR EXTRACTION OF DNA FROM WHOLE BLOOD AND QUANTITATIVE CMV DETECTION BY POLYMERASE CHAIN REACTION	Qi Wei, Norman Jones, Christine Robinson, and Mark Lovell, Department of Pathology, The Children?s Hospital, Aurora, Colorado
S12	DIFERENTIAL DIAGNOSTIC HEPATOTROPIC AND NO HEPATOTROPIC VIRUSES IN MARACAIBO-VENEZUELA- AÑO 2007	Luciana Costa de León, Francisca Monsalve de Castillo, Diana Callejas M, Leticia Porto de Espinoza, Ricardo Atencio, Jesús Estévez, Maria Elena Castellano, and Luz Marina García Laboratorio Regional de Referencia Virológica, Universidad del Zulia, Maracai
S13	PLEXUS EPSTEIN-BARR VIRUS (EBV) IGG AND IGM MULTI-ANALYTE DIAGNOSTICS: MULTIPLEX BEAD-BASED ASSAYS FOR EBV SERUM ANTIBODY DETECTION	Heather Gregson, Nanmei Liu, Tommy Truong, Xin Su, and Lilly Kong Focus Diagnostics, Inc, Cypress, CA.
S14	EVALUATION OF THE PLEXUS EPSTEIN-BARR VIRUS MULTI-ANALYTE PANELS FOR DETECTION OF IGG AND IGM CLASS ANTIBODIES TO EBV	Linda Sherman, Kathy Everhart, Kathy Mack, Douglas Salamon, Amy Leber, and Mario Marcon Department of Lab Medicine, Nationwide Children?s Hospital, Columbus, OH
S15	DETECTION OF HETEROPHILE ANTIBODIES USING A MULTIPLEX FLOW IMMUNOASSAY	Lori J. Misner, Deborah J. Jespersen, Julie A. Harring, Elaine M. Beito, and Matthew J. Binnicker Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905
S16	MULTICENTER QUALITY CONTROL STUDY OF QUANTIFICATION OF EPSTEIN-BARR VIRUS DNA LOAD IN WHOLE BLOOD SPECIMENS BY THE FRENCH ANRS WORKING GROUP AC11	S Fafi-Kremer 1, C Deback 2, C Amiel 3, D Boutolleau 2, M Coste-Burel 4, M Gueudin 5, ME Lafon 6, J Legoff 7, MC Legrand 8, C Lependeven 2, M Leruez-Ville 9, C Mengelle 10, C Payan 8, S Pillet 11, JC Nicolas 3, P Morand 12, and JM Seigneurin 12 Laboratoir
S17	VALIDATION OF ORAGENE DNA SELF- COLLECTION KIT FOR REAL-TIME EBV DNA VIRAL LOAD	D. R. McCclernon1and S. Kleiboeker2 1McClernon LLC, Cary, NC, 2ViraCor Laboratories, Lee?s Summit, Mo
S18	SUSCEPTIBILITY OF EPSTEIN BARR VIRUS (EBV) STRAINS TO CANDIDATE ANTIVIRAL DRUGS	Carol J. Holman, Charlotte A. Romain, and Henry H. Balfour, Jr. Departments of Laboratory Medicine and Pathology, and Pediatrics, University of Minnesota Academic Health Center, Minneapolis, MN
S19	SEROEPIDEMIOLOGY OF ETIOLOGIC AGENTS OF THE ToRCH SYNDROME IN AMERINDIAN WOMEN IN FERTILE AGE FROM ZULIA STATE, VENEZUELA PRELIMINARY RESULTS	Monsalve-Castillo F1, Suárez A2. Atencio R3. Gomez-Gamboa L4, Mindiola R3, Costa L1. Estévez J5, Porto L3, and Callejas D1,3 1Virology Cathedra, Bioanalisis School. 2Experimental Faculty of Sciences, University of Zulia, 3Regional Laboratory of Virology R
S20	HERPES INFECTION OR ITS DIFFERENTIAL DIAGNOSIS PHYTOPHOTODERMATITIS	Karen Marie Carlsen Medical Centres at Gentofte, Frederiksberg and Herlev University Hospitals
S21	EVALUATION OF H&V-MIXTM FRESH CELL FOR THE RAPID TURN-AROUND-TIME IN THE DETECTION OF VZV, HSV, AND CMV	Cherry-Ann Da Costa, Carol Hamilton, Sara T. Beatrice, William R. Oleszko, and Maria Paz Carlos New York City Department of Health and Mental Hygiene, Public Health Laboratory, New York, New York
S22	COMPARISION OF DIRECT FLOURESCENT ANTIBODY (DFA) STAINS FOR THE DETECTION OF HERPES SIMPLEX VIRUS 1 & 2 (HSV 1/2) AND VARICELLA-ZOSTER VIRUS (VZV) IN MRC5 AND H&V-MIXTM SHELL VIAL CULTURES	Jean B. Myers1,2 , Sharon Ryba1, Deirdre Nelson1, Jean M. Hyrek1 and Daniel Amsterdam1,2 1Erie County Medical Center and 2School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, 14215, USA
S23	HERPES ZOSTER WITH MENINGITIS CAUSED BY TWO DIFFERENT VARICELLA VACCINE-ASSOCIATED VARICELLA-ZOSTER VIRUS STRAINS	Myron J. Levin1, Roberta L. DeBiasi2, Vanda Bostik3, and D. Scott Schmid3 1 University of Colorado Health Sciences Center, University of Colorado Denver School of Medicine and Department of Pediatrics, Denver, CO 80262, 2 George Washington University Scho
S24	DETECTION OF VZV IN HSV-NEGATIVE CSF SAMPLES AND HSV IN VZV-NEGATIVE CSF SAMPLES BY SimplexaTM VIRAL ENCEPHALITIS ASSAY	Fan Chen, Huong Mai, Cindy Cheng, Ming-Chou Lee and Lilly Kong Focus Diagnostics Inc., Cypress, CA 90630
S25	COMPARISON OF THE MAGNA PURE EXTRACTOR TO A SWAB LYSIS METHOD FOR THE DETECTION OF HSV AND VZV IN CLINICAL SPECIMENS BY REAL-TIME PCR	Mark J. Espy and Thomas F. Smith Mayo Clinic and Foundation, Rochester, MN
S26	DEVELOPMENT OF A NEW DIAGNOSTIC TOOL FOR THE QUANTITATIVE DETECTION OF HSV-1, HSV-2, AND VZV DNA	Vignoles M., Bes J., Magro S., Raoux N., Barranger C. and Joannes M. Argene, Parc Technologique Delta Sud, 09120 Varilhes, France martine.joannes@argene.com
S27	A SENSITIVE AND SPECIFIC LATERAL-FLOW BASED RAPID POINT-OF-CARE	Andrew Hudak, Erickson Dumaual, Xin Su, and Lilly Kong. Focus Diagnostics, Inc., Cypress, CA 90630.
S28	MORE RAPID ISOLATION OF HERPES SIMPLEX VIRUS STRAINS, RESISTANT TO ACYCLOVIR WITH DIFFERENT tk GENE MUTATIONS IN A CONTINUOUS LINE OF HUMAN RHABDOMYOSARCOMA CELLS THAN IN LARYNGEAL CARCINOMA OR BOVINE KIDNEY CELLS	Petia Genova-Kalou1*, Radostina Alexandrova2, Daniela Dundarova1, Stefan Dundarov, Tatian Varadinova3, Andon Toshev4, Krassimira Idakieva5, and Kamelia Yotovska6 1National Centre of Infectious and Parasitic Diseases, Department of Virology, Laboratory of
S29	COMPARISON OF THE LIAISON® HSV-1 AND HSV-2 TYPE SPECIFIC AUTOMATED IMMUNOASSAYS TO HERPESELECT® 1 AND 2 IMMUNOBLOT	A. Podgorski, E.M. Frenzel, D. Vaught, A. Tuttle, Y. Greenberg, F. A. Blocki, and J. Soldo DiaSorin Inc., Stillwater, MN, 55082
S30	EVALUATION OF ARGENES RESEARCH USE ONLY, REAL-TIME PCR REAGENTS FOR HSV1 AND HSV2 R-GENETM	Anami Patel1, Swati Patel1, Barbara Mason1, and Aaron Pacheco2 1LeBonheur Children?s Medical Center and 2Argene Inc., North Massapequa, NY 11758
S31	EVALUATION OF AN MGB REAL TIME PCR REAGENT FROM NANOGEN FOR HERPES SIMPLEX VIRUS DETECTION AND TYPING	Jeff Stevenson1 and David Hillyard 1,2 1Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology and 2Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, 84108
S32	REAL-TIME PCR DETECTION OF HERPES SIMPLEX VIRUS IN CSF USING THE SPARTAN DXTM	L. Shaw1, A. Rogaeva2, C. Harder2, and T. Karnauchow1,3 1Regional Virology Laboratory, Children?s Hospital of Eastern Ontario; 2 Spartan Bioscience Inc.; and 3University of Ottawa, Ottawa, ON, Canada
S33	CLINICAL RESEARCH STUDY OF ARCHIVED CSF SAMPLES FROM PATIENTS SUSPECTED HERPES SIMPLEX ENCEPHALITIS USING INTELLIGENT MEDICAL DEVICES, INC. HERPES SIMPLEX VIRUS REAL-TIME PCR REAGENTS	Heather L.B. Kiefer1, Damien M. Slater1, William Lauzier1, Lela Dzigua2, Norma P. Tavakoli2,3, Fred D. Lakeman4, James R. Hully1, Thomas H.T. Wang1, Alice A. Jacobs1, and Rich J. Whitley4 1Intelligent Medical Devices, Inc., Cambridge, MA, 2Wadsworth Cente
S34	EVALUATION OF FOUR COMMERCIAL REAL-TIME PCR ANALYTE-SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF HERPES SIMPLEX VIRUS IN CEREBROSPINAL FLUID AND BLOOD	Monique Gaudereault-Keener1, Stephanie Bledsoe1, Richard Buller2, and Gregory A. Storch2 1Saint Louis Children's Hospital and 2Department of Pediatrics, Washington University, St. Louis, MO
S35	PERFORMANCE OF THREE DIFFERENT HSV ID/TYPING ASSAYS FOR DETECTION AND TYPING OF HERPES SIMPLEX VIRUS IN CEREBROSPINAL FLUID	Suresh B. Selvaraju1, Michelle Wurst2, Rebecca T. Horvat2, and Rangaraj Selvarangan1 1Children?s Mercy Hospitals and Clinics, Kansas City, MO 64108 and 2University of Kansas Medical Center, Kansas City, KS 66160
S36	PERFORMANCE OF THREE DIFFERENT HSV ID/TYPING ASSAYS FOR DETECTION AND TYPING OF HERPES SIMPLEX VIRUS IN CEREBROSPINAL FLUID	Suresh B. Selvaraju1, Michelle Wurst2, Rebecca T. Horvat2, and Rangaraj Selvarangan1 1Children?s Mercy Hospitals and Clinics, Kansas City, MO 64108 and 2University of Kansas Medical Center, Kansas City, KS 66160
S37	THE ROLE OF HUMAN HERPES VIRUS 6 IN ENCEPHALITIS PATIENTS	Natasha Huntziker, BA, Shilpa Gavali, MPH, Tasha Padilla, BS, Alex Espinosa, MS, and Carol Glaser, MD, DVM Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA
S38	COMPARISON OF THE MGB ALERT® BK VIRUS 2.0 DETECTION REAGENT ASR (NANOGEN) WITH A -HOME-BREW- TAQMAN ASSAY FOR DETECTION OF BK VIRUS	Joel A. Lefferts, Susan L. Gallagher, Betty J. Dokus and Gregory J. Tsongalis Department of Pathology, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH 03756
S39	EVALUATION OF NANOGEN BK VIRUS ASR FOR BLOOD AND URINE SPECIMENS PERFORMED USING SMARTCYCLER	Jianli Dong, Sergio Rodriguez, and Zhen Yang Molecular Diagnostics Laboratory, Department of Pathology, University of Texas Medical Branch, Galveston, TX
S40	A NEW BK PCR ASSAY WITH IMPROVED DETECTION OF ALL RECENTLY DESCRIBED VARIANT GENOTYPES	Cook, L., Atienza, EA., Hoffman, N. and Jerome, K.R. University of Washington and the Fred Hutchinson Cancer Research Center, Seattle, WA
S41	TRANSPLANT-RELATED VIRAL INFECTION AND CO-INFECTION RATES	Louis Geller and Brent Seaton, PhD Focus Diagnostics, Cypress, CA
S43	GENOTYPING OF MUMPS VIRUS IN CANADA	J Beirnes, J Hiebert, C Sevenhuysen, and GA Tipples Viral Exanthemata Section, National Microbiology Laboratory, Winnipeg, Manitoba, Canada
S44	MUMPS IN CANADA: THE ALBERTA EXPERIENCE 2007 TO NOW	Penny Snook1, Tom Stowe1, Roberta Walle1, Vinod Khurana1, Bonita Lee1, Julie Fox1, 2, Stephanie Yanow1, Graham Tipples3 and Kevin Fonseca1,2 1Provincial Laboratory of Public Health, Calgary & Edmonton sites, 2Microbiology & Infectious Diseases, University
S45	EVALUATION OF A MULTIPLEX IMMUNOASSAY FOR THE SEROLOGIC DETECTION OF IGG CLASS ANTIBODY TO RUBEOLA, MUMPS, RUBELLA AND VARICELLA ZOSTER VIRUS	D.J. Jespersen, Leonard O. Rollins, Julie A. Harring, Elaine M. Beito, and Matthew J. Binnicker Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
S46	DETECTION OF RUBELLA VIRUS RNA IN DRIED BLOOD SPOT AND SERUM SPECIMENS	Qi Zheng, Hong Sun, Emily S. Abernathy, and Joseph P. Icenogle Measles, Mumps, Rubella and Herpes Virus Laboratory Branch, Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, Coordinating Center for Infectious Diseases,
S47	GENOTYPING OF MEASLES VIRUS IN CANADA: 2002 - 2008	J Hiebert, J Beirnes, and GA Tipples Viral Exanthemata Section, National Microbiology Laboratory, Winnipeg, Manitoba, Canada
S48	SYNTHESIS OF A CHIMERIC IGM IMMUNOGLOBULIN SPECIFIC TO THE MEASLES NUCLEOPROTEIN FOR USE AS A POSITIVE CONTROL IN MEASLES DIAGNOSTIC TESTS AND PROFICIENCY PANELS	Hoban, C.1, Tipples, G.1,2, and Berry, J.1,3 1Department of Medical Microbiology, University of Manitoba, 2National Microbiology Laboratory, Public Health Agency of Canada, and 3Department of Immunology, University of Manitoba
S49	USE OF THE MEMBRANE GLYCOPROTEINS OF NIPAH VIRUS TO DEVELOP NEW DIAGNOSTIC TESTS	Azaibi Tamin1, Brian H. Harcourt1, James Roth2, Mike C. Wolf3, Benhur Lee3, Hana Weingartl4, Jean-Christophe Audonnet5, William J. Bellini1and Paul A. Rota1 1Measles, Mumps, Rubella and Herpes Viruses Branch, Division of Viral Diseases, Centers for Diseas
S50	DETECTION OF ADENOVIRUS DNA FROM CLINICAL SPECIMENS USING COMMERCIAL REAL-TIME PCR REAGENTS	Xiaotian Zheng and Yan Mu Children?s Memorial Hospital, Northwestern University, The Feinberg School of Medicine, Chicago, Illinois x-zheng@northwestern.edu
S51	ADENOVIRUS 14 DETECTION AND SURVEILLANCE IN AN OREGON HEALTH SYSTEM FROM 2005-2007	Mary Campbell, John Welle, Curt A. Gleaves, David Gilbert MD and Ron Dworkin MD Infectious Disease & Molecular Diagnostics Laboratory, Providence Health System, Portland, Oregon
S52	REAL-TIME PCR WITH AN INTERNAL CONTROL DETECTING ALL KNOWN HUMAN ADENOVIRUS SEROTYPES	Marjolein Damen2,3, René Minnaar1, Patricia Glasius1, Alwin van der Ham1, Pauline Wertheim1, and Marcel Beld1* 1Laboratory of Clinical Virology, Department of Medical Microbiology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherla
S53	MOLECULAR AND PHENOTYPIC CHARACTERIZATION OF EMERGING ADENOVIRUS 14 STRAIN ASSOCIATED WITH RECENT OUTBREAKS OF RESPIRATORY DISEASE IN THE UNITED STATES	Adriana E. Kajon1, Xiaoyan Lu 2, Dean D. Erdman2, David Schnurr3, and David Metzgar4 1-Infectious Disease Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA,. 2-Division of Viral Diseases, Centers for Disease Control and Prevention, At
S54	A COMMERCIAL REAL TIME PCR FOR ADENOVIRUSES	M. Echavarria1, R. Gainotti1, S. Magro2, C. Barranger2, M. Joannes2 and G. Carballal1 1Clinical Virology Laboratory, CEMIC University Hospital, Argentina and 2ARGENE, Parc Technologique Delta Sud, France
S55	REAL-TIME PCR FOR RAPID DETERMINATION OF ANTIVIRAL DRUG SUSCEPTIBILITY OF ADENOVIRUS	R. Gainotti a, M. Echavarría a, C. Ricarte a, C. Videla a, G. Carballal a, and E. Damonte b aLaboratorio de Virología Clínica, CEMIC, Buenos Aires, Argentina and bLaboratorio de Virología, Departamento de Química Biológica, Facultad de Ciencias Exactas y
S56	ADENOVIRUSES DETECTED IN AUTOPSIES, NEW YORK, 2007	Lisa Mingle, Kimberly Rush-Wilson, and Kirsten St. George Clinical Virology Program, Wadsworth Center, New York State Department of Health Albany, New York
S57	RAPID, SENSITIVE, SPECIFIC DETECTION OF ENTEROVIRUSES AND RHINOVIRUSES USING A REAL-TIME PCR FOR ENTEROVIRUSES THAT DETECTS ALL RHINOVIRUSES BY GEL ELECTROPHORESIS	Tasha Padilla, Shigeo Yagi, and David P. Schnurr Viral and Rickettsial Disease Laboratory, California Department of Public Health, 850 Marina Bay Parkway, Richmond, CA 94804
S58	RT-PCR ASSAYS USED TO IDENTIFY NEW HUMAN RHINOVIRUSES	Xiaoyan Lu and Dean D. Erdman Gastroenteritis and Respiratory Virus Laboratory Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA
S59	DETECTION OF HUMAN RHINOVIRUSES BY REAL TIME PCR	Michael S. Forman, Susan H. Clemens, Linda L. Gluck, and Alexandra Valsamakis Division of Medical Microbiology, Department of Pathology, The Johns Hopkins Medical Institution, Baltimore, MD.
S60	SYBR GREEN I-BASED REAL-TIME PCR REVEALED A HIGH INCIDENCE OF HUMAN BOCAVIRUS (HBOV) INFECTION IN THE PEDIATRIC POPULATION FROM PORTO ALEGRE, BRAZIL	Vlademir V. Cantarelli1,2, Diogo A. Pilger1, Fabiana de Souza Pereira1, Luciano P. Santos1, Lisiane Turatti1, and Sergio L. Amantea3,4 1Dept of Microbiology and Molecular Biology, Weinmann Laboratorio, Porto Alegre, RS, Brazil, 2Centro Universitario Feeva
S61	DEVELOPMENT, EVALUATION AND COMPARISON OF REAL-TIME PCR ASSAYS FOR DETECTION OF HUMAN BOCAVIRUS IN RESPIRATORY SAMPLES	Sheila Braun1, Sallene Wong1, Kanti Pabbaraju1, Sushma Kothapalli1 and Julie D Fox1,2 1Provincial Laboratory for Public Health (Microbiology), Calgary, Alberta, Canada and 2Department of Microbiology and Infectious Diseases, University of Calgary, Calgary
S62	SEVERE DISEASE ASSOCIATED WITH ACUTE HUMAN BOCAVIRUS INFECTION	Tobias Allander1, Anna Lindblom1, Paul Castillo1, Maria Rotzén-Östlund1, Annika Tiveljung-Lindell1, Klaus Hedman2, and Maria Söderlund-Venermo2 1Karolinska University Hospital, Stockholm, Sweden and 2University of Helsinki, Helsinki, Finland
S442	EVALUATION OF ASSAYS FOR THE RAPID DIAGNOSIS OF MUMPS VIRUS RNA IN CLINICAL SPECIMENS	P. Thirukkumaran1, V. Khurana1, S. Shokoples1, G. Appleyard1, J. D. Fox1,2, S. Yanow1, K. Fonsec Provincial Laboratory for Public Health (Microbiology), and 1,2Microbiology & Infectious Diseases, University of Calgary, Calgary, AB.